DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+1.33%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$4.76B
AUM Growth
+$4.76B
(-6%)
Cap. Flow
-$651M
Cap. Flow
% of AUM
-13.68%
Top 10 Holdings %
Top 10 Hldgs %
31.51%
Holding
169
New
40
Increased
23
Reduced
18
Closed
45
Top Buys
| 1 |
Edgewise Therapeutics
EWTX
|
$128M |
| 2 |
Boston Scientific
BSX
|
$110M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$88.6M |
| 4 |
Neurocrine Biosciences
NBIX
|
$70.5M |
| 5 |
Organogenesis Holdings
ORGO
|
$54.6M |
Top Sells
| 1 |
Nkarta
NKTX
|
$87.3M |
| 2 |
SWTX
SpringWorks Therapeutics
SWTX
|
$65.1M |
| 3 |
OSH
Oak Street Health, Inc.
OSH
|
$58.2M |
| 4 |
DFPHU
DFP Healthcare Acquisitions Corp. Unit
DFPHU
|
$56.1M |
| 5 |
DFHTU
Deerfield Healthcare Technology Acquisitions Corp. Unit
DFHTU
|
$50.4M |
Sector Composition
| 1 | Healthcare | 70.89% |
| 2 | Consumer Discretionary | 0.23% |
| 3 | Industrials | 0% |
